Trial · NCT07549295
Melatonin and Perinatal Outcomes in MVM-Related Fetal Growth Restriction (MIMVMFGR)
NCT07549295, Phase 1, Enrolling by invitation, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Melatonin and Perinatal Outcomes in MVM-Related Fetal Growth Restriction (MIMVMFGR). Trials, record NCT07549295. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07549295
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Melatonin and Perinatal Outcomes in MVM-Related Fetal Growth Restriction (MIMVMFGR)
- NCT number
- NCT07549295
- Status
- Enrolling by invitation
- Phases
- Phase 1
- Enrollment
- 240 participants, estimated
- Lead sponsor
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
- Conditions
- Fetal Growth Restriction (FGR)
- Interventions
- Melatonin, Placebo
- First posted
- 2026-04-24
- Last updated
- 2026-04-24
Source ClinicalTrials.gov
Registered outcomes10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | IUFD and neonatal death | during the whole pregnancy and born within 28 days | intrauterine fetal death and neonatal death |
| Primary | severe neonatal complications. | born within 28 days | severe neonatal complications ( including neonatal necroticing enterocolitis, Respiratory Distress Syndrome, neonatal septicemnia, Periventricular-intraventricular hemorrhage). |
| Secondary | interval from treatment to delivery | during the whole pregnancy | the interval from treatment initiation to delivery (day); |
| Secondary | delivery GA | the day at delivery | gestational age at delivery (week) |
| Secondary | fetal growth trajectory throughout pregnancy | during the whole pregnancy | fetal growth trajectory throughout pregnancy (slope of Z-score over time estimated using a linear mixed model, LMM); |
| Secondary | neonatal birth weight | the day at delivery | neonatal birth weight(g) |
| Secondary | Apgar score | the day at delivery | neonatal Apgar score |
| Secondary | maternal complications | during pregnancy | including gestational hypertension, preeclampsia, and placental abruption |
| Other | Long-term neurodevelopmental outcomes of the infant | within 2 years after baby is born | Incidence of cerebral palsy, and neurodevelopmental assessment (the Bayley Scales of Infant and Toddler Development). |
| Other | effect of melatonin on placental oxidative stress levels | the delivery day | placental Malondialdehyde (MDA) levels, superoxide dismutase (SOD), and placental growth factor (PlGF) activity |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07549295
GET https://conductscience.org/api/trials/v1/NCT07549295/registered